Discoveries for life™




We are committed to bringing novel drugs and innovative new treatments to CNS disorders as rapidly as possible, bringing new hope to patients and value to our shareholders.

For investor enquiries about Proximagen, please contact:




+44 (0)20 7400 7700
media@proximagen.com